Matches in SemOpenAlex for { <https://semopenalex.org/work/W4242442457> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- W4242442457 endingPage "395" @default.
- W4242442457 startingPage "387" @default.
- W4242442457 abstract "This study was designed to clarify whether gene expression in the cardiac sarcoplasmic reticulum [sarcoplasmic reticulum Ca2+-ATPase (SERCA), phospholamban, ryanodine receptor and calsequestrin] changes in accordance with left ventricular functional alterations in the volume-overloaded heart. Further, the effect of the angiotensin II type 1 receptor antagonist, TCV-116, on the expression of these genes was also evaluated. Left ventricular fractional shortening was significantly increased at 7 days, had returned to control levels at 21 days, and had significantly decreased at 35 days after the shunt operation, compared with sham-operated rats. The level of SERCA mRNA was significantly decreased at both 21 days and 35 days after the shunt operation. The levels of ryanodine receptor and phospholamban mRNAs were significantly decreased at 35 days in shunt-operated rats. The decrease in the SERCA mRNA level preceded the development of cardiac dysfunction. The levels of SERCA and ryanodine receptor mRNAs were correlated positively with left ventricular fractional shortening (r = 0.73, P< 0.0001 and r = 0.61, P< 0.01 respectively). Attenuation of the decrease in left ventricular fractional shortening occurred on treatment with TCV-116. After the treatment with TCV-116, the levels of SERCA and phospholamban mRNAs were restored to the respective values in sham-operated rats. Ryanodine receptor mRNA levels remained unchanged after treatment with TCV-116. These results indicate that the down-regulation of SERCA and ryanodine receptor mRNA levels may be related to cardiac dysfunction in the volume-overloaded heart. In addition, treatment with an angiotensin II receptor antagonist may restore the altered sarcoplasmic reticulum mRNA levels to control levels, and this may result in attenuation of the functional impairment in the volume-overloaded heart." @default.
- W4242442457 created "2022-05-12" @default.
- W4242442457 creator A5051920182 @default.
- W4242442457 creator A5060588178 @default.
- W4242442457 creator A5061777040 @default.
- W4242442457 date "1999-04-01" @default.
- W4242442457 modified "2023-09-23" @default.
- W4242442457 title "Serial changes in sarcoplasmic reticulum gene expression in volume-overloaded cardiac hypertrophy in the rat: effect of an angiotensin II receptor antagonist" @default.
- W4242442457 doi "https://doi.org/10.1042/cs0960387" @default.
- W4242442457 hasPublicationYear "1999" @default.
- W4242442457 type Work @default.
- W4242442457 citedByCount "6" @default.
- W4242442457 countsByYear W42424424572016 @default.
- W4242442457 crossrefType "journal-article" @default.
- W4242442457 hasAuthorship W4242442457A5051920182 @default.
- W4242442457 hasAuthorship W4242442457A5060588178 @default.
- W4242442457 hasAuthorship W4242442457A5061777040 @default.
- W4242442457 hasConcept C113217602 @default.
- W4242442457 hasConcept C126322002 @default.
- W4242442457 hasConcept C134018914 @default.
- W4242442457 hasConcept C158617107 @default.
- W4242442457 hasConcept C170493617 @default.
- W4242442457 hasConcept C17137333 @default.
- W4242442457 hasConcept C181199279 @default.
- W4242442457 hasConcept C185592680 @default.
- W4242442457 hasConcept C190712762 @default.
- W4242442457 hasConcept C23265538 @default.
- W4242442457 hasConcept C2775953344 @default.
- W4242442457 hasConcept C2778198053 @default.
- W4242442457 hasConcept C2781414619 @default.
- W4242442457 hasConcept C2908929049 @default.
- W4242442457 hasConcept C55493867 @default.
- W4242442457 hasConcept C71924100 @default.
- W4242442457 hasConcept C86803240 @default.
- W4242442457 hasConcept C95444343 @default.
- W4242442457 hasConceptScore W4242442457C113217602 @default.
- W4242442457 hasConceptScore W4242442457C126322002 @default.
- W4242442457 hasConceptScore W4242442457C134018914 @default.
- W4242442457 hasConceptScore W4242442457C158617107 @default.
- W4242442457 hasConceptScore W4242442457C170493617 @default.
- W4242442457 hasConceptScore W4242442457C17137333 @default.
- W4242442457 hasConceptScore W4242442457C181199279 @default.
- W4242442457 hasConceptScore W4242442457C185592680 @default.
- W4242442457 hasConceptScore W4242442457C190712762 @default.
- W4242442457 hasConceptScore W4242442457C23265538 @default.
- W4242442457 hasConceptScore W4242442457C2775953344 @default.
- W4242442457 hasConceptScore W4242442457C2778198053 @default.
- W4242442457 hasConceptScore W4242442457C2781414619 @default.
- W4242442457 hasConceptScore W4242442457C2908929049 @default.
- W4242442457 hasConceptScore W4242442457C55493867 @default.
- W4242442457 hasConceptScore W4242442457C71924100 @default.
- W4242442457 hasConceptScore W4242442457C86803240 @default.
- W4242442457 hasConceptScore W4242442457C95444343 @default.
- W4242442457 hasIssue "4" @default.
- W4242442457 hasLocation W42424424571 @default.
- W4242442457 hasOpenAccess W4242442457 @default.
- W4242442457 hasPrimaryLocation W42424424571 @default.
- W4242442457 hasRelatedWork W123622833 @default.
- W4242442457 hasRelatedWork W1976614674 @default.
- W4242442457 hasRelatedWork W1991421066 @default.
- W4242442457 hasRelatedWork W2034547248 @default.
- W4242442457 hasRelatedWork W2067612902 @default.
- W4242442457 hasRelatedWork W2067727865 @default.
- W4242442457 hasRelatedWork W2165996901 @default.
- W4242442457 hasRelatedWork W2171219498 @default.
- W4242442457 hasRelatedWork W2938553505 @default.
- W4242442457 hasRelatedWork W38621135 @default.
- W4242442457 hasVolume "96" @default.
- W4242442457 isParatext "false" @default.
- W4242442457 isRetracted "false" @default.
- W4242442457 workType "article" @default.